Highlights

  • Zycov D likely to be available from October
  • Deemed safe for children above 12 years of age
  • 3 doses with 28 day intervals recommended

Latest news

AI next big infrastructure like electricity, internet, must reach every citizen: Tata Sons Chairman N Chandrasekaran

AI next big infrastructure like electricity, internet, must reach every citizen: Tata Sons Chairman N Chandrasekaran

Kristen Bell joins cast of live action film 'Sonic of Hedgehog 4'

Kristen Bell joins cast of live action film 'Sonic of Hedgehog 4'

Nifty, Sensex open higher on FII inflows and DII buying; experts cautious amid global risks, hawkish Fed outlook

Nifty, Sensex open higher on FII inflows and DII buying; experts cautious amid global risks, hawkish Fed outlook

PM Modi meets Google CEO Sundar Pichai, discusses AI collaborations

PM Modi meets Google CEO Sundar Pichai, discusses AI collaborations

Brevis, bowlers make short work of UAE as SA finish group stage with all-win record

Brevis, bowlers make short work of UAE as SA finish group stage with all-win record

PM Modi meets president of Spain, PM of Finland; says India-EU FTA ushers in golden era

PM Modi meets president of Spain, PM of Finland; says India-EU FTA ushers in golden era

Screenwriter Salim Khan on ventilator support and stable, say doctors

Screenwriter Salim Khan on ventilator support and stable, say doctors

Gaurav Gogoi just face of Assam Congress, Rakibul Hussain its 'sole base': Bhupen Borah

Gaurav Gogoi just face of Assam Congress, Rakibul Hussain its 'sole base': Bhupen Borah

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above.”

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Zydus Cadila's covid vaccine ZyCoV-D is set to be launched in India in October and is deemed for safe for kids above 12. This 'third-generation triple dose vaccine' could just be the answer to fill the gap of 100 crore doses required by year-end to vaccinate the vast majority of the adult population. Here is everything you need to know about this non-injecting, DNA vaccine which even children above 12 can take.

Meet Cadila’s ZyCoV-D

  • It is the world’s first DNA vaccine to protect against Covid 19. Requires a triple dose for immunity and showcased 67% efficacy in trials. The vaccine is deemed safe for children above the age of 12.

What kind of vaccine is it? How is it different than Covishield and Covaxin?

  • Cadila’s ZyCoV-D is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen like Covaxin.

How does a DNA vaccine work?

  • Often referred to as the third-generation vaccines, the dose carries the genetic code of the virus that triggers the build up of immunity in one's body.
  • Zydus stated that the plasmid DNA platform is “ideally suited for dealing with Covid-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring”.

Is a DNA vaccine being used anywhere else in the world?

  • No DNA vaccine has been widely used against any disease so far, but they are more stable and easier to store than mRNA shots (tech used by Pfizer & Moderna)
  • According to the U.S. National Library of Medicine, over 160 different DNA vaccines are currently being tested in human clinical trials in the United States. It is estimated that 62% of these trials are devoted to cancer vaccines and 33% are applied for vaccines against human immunodeficiency virus (HIV).

How many doses does one need?

  • Unlike most other Covid-19 vaccines, which require two doses for full immunity, ZyCoV-D is administered in three doses. The vaccine is also needle-free.
  • The doses will be administered 28 days apart

Needle-free vaccine, how does one get the dose?

  • Doses are given using a device that delivers fluid through a spring-powered jet that penetrates the skin, developed by Pharmajet’s Tropis.
  • Zydus Cadila claims this method of delivery is painless and could also reduce side effects from the jab

Is it safe? What are the trial results showing?

  • The vaccine has been tested on almost 30,000 participants across Phase I, II and III studies, and is the first vaccine in India to be tested on 12 to 18-year-olds. Around 1,000 participants were enrolled in the adolescent age group, among whom the vaccine was found to be safe and well-tolerated, with similar findings in the adult population

ADVERTISEMENT

Up Next

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

ADVERTISEMENT

editorji-whatsApp

More videos

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

Explained: India-US trade deal, tariffs and trade benefits

Explained: India-US trade deal, tariffs and trade benefits

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

President Trump announces US-India trade deal, lowers tariffs from 25 pc to 18 pc

President Trump announces US-India trade deal, lowers tariffs from 25 pc to 18 pc

Stock markets cheer India-US trade deal: Sensex jumps over 5 pc; Nifty nears all-time high

Stock markets cheer India-US trade deal: Sensex jumps over 5 pc; Nifty nears all-time high

Sustaining 7–8% growth top priority to create jobs: FM Nirmala Sitharaman

Sustaining 7–8% growth top priority to create jobs: FM Nirmala Sitharaman

Budget FY27 demonstrates commitment to macro stability: Fitch

Budget FY27 demonstrates commitment to macro stability: Fitch

STT hike on Futures dampen stock market sentiment; Sensex, Nifty crash nearly 2 pc

STT hike on Futures dampen stock market sentiment; Sensex, Nifty crash nearly 2 pc

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.